ACA
GILD icon

Apis Capital Advisors’s Gilead Sciences GILD Stock Holding History

Apis Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$2.95M Buy
30,000
+1,800
+6% +$200K 4.08% 10
2015
Q2 		$3.3M Buy
+28,200
New +$3.08M 3.71% 12

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Apis Capital Advisors's GILD Position: Q3 2015 in Review

Apis Capital Advisors increased its Gilead Sciences (GILD) stake by 6.4% in Q3 2015, buying an estimated $200K and bringing the position to 30,000 shares worth $2.95M. The position accounts for 4.08% of the portfolio, ranked #10.

Apis Capital Advisors first reported a position in GILD in Q2 2015 and has held it in 2 quarters since. The position peaked at $3.3M in Q2 2015. 1,573 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

  • Apis Capital Advisors held 30,000 shares of Gilead Sciences worth $2.95M as of Q3 2015.
  • Apis Capital Advisors bought 1,800 Gilead Sciences shares in Q3 2015, an estimated $200K.
  • Gilead Sciences made up 4.08% of Apis Capital Advisors's portfolio in Q3 2015, its #10 holding.
  • Apis Capital Advisors first reported a position in Gilead Sciences in Q2 2015 and has held it in 2 quarters since.
  • Apis Capital Advisors's Gilead Sciences position peaked at $3.3M in Q2 2015.
  • 1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on Apis Capital Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.